NRIX insider filings

Nurix Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-04. Screen NRIX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 10 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Ring Christine — Chief Legal Officer4—7 legs · 32,245 sh · $819,11212
GREGORY JULIA P — Director1—1 leg · 22,583 sh · $528,5282
Hansen Gwenn — Chief Scientific Officer3—4 legs · 8,313 sh · $216,18212
van Houte Hans — Chief Financial Officer2—3 legs · 7,603 sh · $149,0376

Recent insider filings — Nurix Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-11-044van Houte Hans — Chief Financial OfficerSale (S): 3,300 @ $15.38 · Sale (S): 1,469 @ $16.20EDGAR
2026-11-044Ring Christine — Chief Legal OfficerOption exercise (M): 5,786 @ $8.72 · Sale (S): 9,527 @ $25.74 · Sale (S): 1,075 @ $26.76 · Sale (S): 6,113 @ $25.83 · Option exercise (M): 5,786 (derivative) @ $0EDGAR
2026-11-024van Houte Hans — Chief Financial OfficerOption exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Option exercise (M): 3,573 @ $0 · Sale (S): 2,834 @ $26.28 · Option exercise (M): 3,750 (derivative) @ $0 · Option exercise (M): 2,859 (derivative) @ $0 · +1 moreEDGAR
2026-11-024Ring Christine — Chief Legal OfficerOption exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Option exercise (M): 3,573 @ $0 · Sale (S): 3,957 @ $26.28 · Option exercise (M): 3,750 (derivative) @ $0 · Option exercise (M): 2,859 (derivative) @ $0 · +1 moreEDGAR
2026-11-024Hansen Gwenn — Chief Scientific OfficerOption exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Option exercise (M): 3,573 @ $0 · Sale (S): 3,957 @ $26.28 · Option exercise (M): 1,452 @ $1.86 · Sale (S): 1,452 @ $26.80 · +4 moreEDGAR
2026-10-154Hansen Gwenn — Chief Scientific OfficerOption exercise (M): 1,452 @ $1.86 · Sale (S): 1,452 @ $25 · Option exercise (M): 1,452 (derivative) @ $0EDGAR
2026-10-144GREGORY JULIA P — DirectorOption exercise (M): 22,583 @ $1.86 · Sale (S): 22,583 @ $23.40 · Option exercise (M): 22,583 (derivative) @ $0EDGAR
2026-10-024Ring Christine — Chief Legal OfficerOption exercise (M): 5,786 @ $8.72 · Sale (S): 5,786 @ $23.19 · Option exercise (M): 5,786 (derivative) @ $0EDGAR
2026-09-024Ring Christine — Chief Legal OfficerOption exercise (M): 5,787 @ $8.72 · Sale (S): 5,387 @ $25.69 · Sale (S): 400 @ $26.64 · Option exercise (M): 5,787 (derivative) @ $0EDGAR
2026-09-014Hansen Gwenn — Chief Scientific OfficerOption exercise (M): 1,452 @ $1.86 · Sale (S): 1,452 @ $25.47 · Option exercise (M): 1,452 (derivative) @ $0EDGAR
2026-08-054Hansen Gwenn — Chief Scientific OfficerOption exercise (M): 4,356 @ $1.86 · Sale (S): 4,356 @ $25 · Option exercise (M): 4,356 (derivative) @ $0EDGAR
2026-08-054Hansen Gwenn — Chief Scientific OfficerSale (S): 1,500 @ $23.87 · Sale (S): 2,611 @ $24.64EDGAR
2026-08-044van Houte Hans — Chief Financial OfficerSale (S): 1,794 @ $23.89 · Sale (S): 2,967 @ $24.65EDGAR
2026-08-034Ring Christine — Chief Legal OfficerOption exercise (M): 5,787 @ $8.72 · Sale (S): 16,589 @ $23.05 · Option exercise (M): 5,787 (derivative) @ $0EDGAR
2026-07-304van Houte Hans — Chief Financial OfficerOption exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Option exercise (M): 3,572 @ $0 · Sale (S): 2,845 @ $23.38 · Option exercise (M): 3,750 (derivative) @ $0 · Option exercise (M): 2,858 (derivative) @ $0 · +1 moreEDGAR
2026-07-304Ring Christine — Chief Legal OfficerOption exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Option exercise (M): 3,572 @ $0 · Sale (S): 3,847 @ $23.38 · Option exercise (M): 3,750 (derivative) @ $0 · Option exercise (M): 2,858 (derivative) @ $0 · +1 moreEDGAR
2026-07-304Hansen Gwenn — Chief Scientific OfficerOption exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Option exercise (M): 3,572 @ $0 · Sale (S): 3,847 @ $23.38 · Option exercise (M): 3,750 (derivative) @ $0 · Option exercise (M): 2,858 (derivative) @ $0 · +1 moreEDGAR
2026-07-024Ring Christine — Chief Legal OfficerOption exercise (M): 5,221 @ $1.86 · Option exercise (M): 5,787 @ $8.72 · Sale (S): 11,008 @ $23.56 · Option exercise (M): 5,221 (derivative) @ $0 · Option exercise (M): 5,787 (derivative) @ $0EDGAR
2026-06-254Ring Christine — Chief Legal OfficerOption exercise (M): 13,333 @ $7.26 · Option exercise (M): 15,602 @ $8.72 · Sale (S): 28,935 @ $20.06 · Option exercise (M): 13,333 (derivative) @ $0 · Option exercise (M): 15,602 (derivative) @ $0EDGAR
2026-06-254Hansen Gwenn — Chief Scientific OfficerSale (S): 5,394 @ $20EDGAR
2026-06-024Ring Christine — Chief Legal OfficerOption exercise (M): 3,422 @ $1.86 · Sale (S): 8,148 @ $16.60 · Option exercise (M): 3,422 (derivative) @ $0EDGAR
2026-05-154Saltzman Edward C — DirectorGrant/award (A): 31,250 (derivative) @ $0EDGAR
2026-05-154DANSEY ROGER D — DirectorGrant/award (A): 31,250 (derivative) @ $0EDGAR
2026-05-154Lacey David L. — DirectorGrant/award (A): 31,250 (derivative) @ $0EDGAR
2026-05-154Kapur Anil — DirectorGrant/award (A): 31,250 (derivative) @ $0EDGAR
2026-05-154Baynes Roy D. — DirectorGrant/award (A): 31,250 (derivative) @ $0EDGAR
2026-05-154Silva Paul M — DirectorGrant/award (A): 31,250 (derivative) @ $0EDGAR
2026-05-154Reinsdorf Judith A — DirectorGrant/award (A): 31,250 (derivative) @ $0EDGAR
2026-05-154GREGORY JULIA P — DirectorGrant/award (A): 31,250 (derivative) @ $0EDGAR
2026-05-054van Houte Hans — Chief Financial OfficerSale (S): 13,473 @ $16.58 · Sale (S): 582 @ $17.18EDGAR
2026-05-044Ring Christine — Chief Legal OfficerSale (S): 8,148 @ $16.96EDGAR
2026-05-014Ring Christine — Chief Legal OfficerSale (S): 5,394 @ $16.76EDGAR
2026-04-304van Houte Hans — Chief Financial OfficerOption exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 2,388 @ $16.65 · Option exercise (M): 2,000 (derivative) @ $0 · Option exercise (M): 3,750 (derivative) @ $0 · +1 moreEDGAR
2026-04-304Ring Christine — Chief Legal OfficerOption exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 3,214 @ $16.65 · Option exercise (M): 2,000 (derivative) @ $0 · Option exercise (M): 3,750 (derivative) @ $0 · +1 moreEDGAR
2026-04-304Hansen Gwenn — Chief Scientific OfficerOption exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 3,214 @ $16.65 · Option exercise (M): 2,000 (derivative) @ $0 · Option exercise (M): 3,750 (derivative) @ $0 · +1 moreEDGAR
2026-04-024Ring Christine — Chief Legal OfficerSale (S): 8,148 @ $15.24EDGAR
2026-03-024Ring Christine — Chief Legal OfficerSale (S): 8,148 @ $15.44EDGAR
2026-02-104van Houte Hans — Chief Financial OfficerGrant/award (A): 93,750 (derivative) @ $0 · Grant/award (A): 42,875 (derivative) @ $0EDGAR
2026-02-104Ring Christine — Chief Legal OfficerGrant/award (A): 93,750 (derivative) @ $0 · Grant/award (A): 42,875 (derivative) @ $0EDGAR
2026-02-104Hansen Gwenn — Chief Scientific OfficerGrant/award (A): 93,750 (derivative) @ $0 · Grant/award (A): 42,875 (derivative) @ $0EDGAR
2026-02-104SANDS ARTHUR T — President, CEO, DirectorGrant/award (A): 562,500 (derivative) @ $0EDGAR
2026-02-094Ring Christine — Chief Legal OfficerSale (S): 14,261 @ $16.66EDGAR
2026-02-034Hansen Gwenn — Chief Scientific OfficerOption exercise (M): 31,333 @ $0.84 · Option exercise (M): 31,333 (derivative) @ $0EDGAR
2026-01-304van Houte Hans — Chief Financial OfficerOption exercise (M): 2,887 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Sale (S): 3,588 @ $16.58 · Sale (S): 73 @ $17.37 · +4 moreEDGAR
2026-01-304Ring Christine — Chief Legal OfficerOption exercise (M): 1,925 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Sale (S): 4,333 @ $16.58 · Sale (S): 88 @ $17.37 · +4 moreEDGAR
2026-01-304Hansen Gwenn — Chief Scientific OfficerOption exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Sale (S): 4,797 @ $16.58 · Sale (S): 98 @ $17.37 · +4 moreEDGAR
2026-01-204Ring Christine — Chief Legal OfficerOption exercise (M): 3,760 @ $1.86 · Sale (S): 3,760 @ $18.42 · Option exercise (M): 3,760 (derivative) @ $0EDGAR
2025-12-184Ring Christine — Chief Legal OfficerOption exercise (M): 3,760 @ $1.86 · Sale (S): 3,560 @ $17.87 · Sale (S): 200 @ $18.55 · Option exercise (M): 3,760 (derivative) @ $0EDGAR
2025-11-244Ring Christine — Chief Legal OfficerOption exercise (M): 37,600 @ $1.86 · Sale (S): 37,600 @ $17.07 · Option exercise (M): 37,600 (derivative) @ $0EDGAR
2025-11-104DANSEY ROGER D — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR

Recent 8-K events — Nurix Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-038-K8.01 — Other EventsEDGAR
2026-10-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-118-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-088-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-158-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-088-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-068-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-288-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-128-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=NRIX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs